Best Biotech Stocks to Buy Now (2024)Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.
Industry: Biotechnology
| Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ADIL | ADIAL PHARMACEUTICALS INC | $7.01M | $1.73 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| ACLX | ARCELLX INC | $2.71B | $51.38 | $79.33 | 54.40% | Strong Buy | 9 | 4.24% | N/A | N/A | N/A | ||||
| ACRV | ACRIVON THERAPEUTICS INC | $191.73M | $8.47 | $19.80 | 133.77% | Strong Buy | 5 | N/A | N/A | N/A | N/A | ||||
| AEZS | AETERNA ZENTARIS INC | $9.52M | $1.96 | $15.00 | 665.31% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| ANTX | AN2 THERAPEUTICS INC | $67.88M | $2.28 | $6.50 | 185.09% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| AVTE | AEROVATE THERAPEUTICS INC | $601.00M | $21.57 | $50.00 | 131.80% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| ENTA | ENANTA PHARMACEUTICALS INC | $264.03M | $12.48 | $20.75 | 66.27% | Hold | 4 | 1.61% | N/A | N/A | N/A | ||||
| CTXR | CITIUS PHARMACEUTICALS INC | $116.62M | $0.73 | $4.00 | 445.70% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| DAWN | DAY ONE BIOPHARMACEUTICALS INC | $1.15B | $13.21 | $39.67 | 200.28% | Strong Buy | 6 | N/A | N/A | N/A | N/A | ||||
| CYTO | ALTAMIRA THERAPEUTICS LTD | $2.36M | $1.60 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| GLUE | MONTE ROSA THERAPEUTICS INC | $273.34M | $5.45 | $11.00 | 101.83% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| GRTS | GRITSTONE BIO INC | $74.92M | $0.76 | $6.00 | 685.34% | Buy | 2 | 73.24% | N/A | N/A | N/A | ||||
| IGC | IGC PHARMA INC | $27.41M | $0.43 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| IONS | IONIS PHARMACEUTICALS INC | $6.10B | $41.84 | $56.78 | 35.70% | Buy | 9 | 10.52% | N/A | N/A | N/A | ||||
| NKTR | NEKTAR THERAPEUTICS | $242.38M | $1.32 | $1.00 | -24.24% | Hold | 1 | -12.51% | N/A | N/A | N/A | ||||
| JSPR | JASPER THERAPEUTICS INC | $319.05M | $21.18 | $71.67 | 238.37% | Buy | 3 | N/A | N/A | N/A | N/A | ||||
| LIPO | LIPELLA PHARMACEUTICALS INC | $4.43M | $0.71 | $2.00 | 182.09% | Strong Buy | 1 | N/A | N/A | N/A | N/A | ||||
| TENX | TENAX THERAPEUTICS INC | $7.05M | $3.60 | $30.00 | 733.33% | Strong Buy | 1 | N/A | N/A | N/A | N/A | ||||
| TCON | TRACON PHARMACEUTICALS INC | $4.07M | $1.79 | $60.00 | 3,251.96% | Buy | 1 | 50.59% | N/A | N/A | N/A | ||||
| SONN | SONNET BIOTHERAPEUTICS HOLDINGS INC | $5.40M | $1.76 | $18.50 | 951.14% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| UBX | UNITY BIOTECHNOLOGY INC | $24.84M | $1.48 | $9.00 | 508.11% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| OBIO | ORCHESTRA BIOMED HOLDINGS INC | $158.85M | $4.44 | $17.00 | 282.88% | Strong Buy | 2 | 3.21% | N/A | N/A | N/A | ||||
| VBIV | VBI VACCINES INC | $17.03M | $0.60 | N/A | N/A | N/A | N/A | 88.33% | N/A | N/A | N/A | ||||
| VALN | VALNEVA SE | $524.39M | $7.55 | $21.50 | 184.77% | Strong Buy | 2 | 30.41% | N/A | N/A | N/A | ||||
| VKTX | VIKING THERAPEUTICS INC | $7.59B | $68.86 | $112.25 | 63.01% | Strong Buy | 8 | N/A | N/A | N/A | N/A | ||||
| TRDA | ENTRADA THERAPEUTICS INC | $415.31M | $12.36 | $21.00 | 69.90% | Buy | 2 | -38.20% | N/A | N/A | N/A | ||||
| TCBP | TC BIOPHARM (HOLDINGS) PLC | $5.02M | $1.57 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| ABUS | ARBUTUS BIOPHARMA CORP | $488.22M | $2.72 | $4.33 | 59.30% | Strong Buy | 3 | -15.54% | N/A | N/A | N/A | ||||
| NUVL | NUVALENT INC | $4.23B | $66.07 | $101.83 | 54.13% | Strong Buy | 6 | N/A | N/A | N/A | N/A | ||||
| PYXS | PYXIS ONCOLOGY INC | $249.97M | $4.30 | $8.50 | 97.67% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| IKT | INHIBIKASE THERAPEUTICS INC | $12.31M | $1.90 | $27.00 | 1,321.05% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| GANX | GAIN THERAPEUTICS INC | $49.79M | $3.07 | $8.00 | 160.59% | Strong Buy | 3 | 36.39% | N/A | N/A | N/A | ||||
| MRSN | MERSANA THERAPEUTICS INC | $345.71M | $2.85 | $6.33 | 122.21% | Buy | 6 | -10.62% | N/A | N/A | N/A | ||||
| XNCR | XENCOR INC | $1.18B | $19.23 | $35.14 | 82.75% | Strong Buy | 7 | -12.48% | N/A | N/A | N/A | ||||
| ASND | ASCENDIS PHARMA A | $7.90B | $136.93 | $181.86 | 32.81% | Strong Buy | 7 | 61.02% | N/A | N/A | N/A | ||||
| LGVN | LONGEVERON INC | $4.20M | $1.67 | $60.00 | 3,492.81% | Buy | 1 | 157.25% | N/A | N/A | N/A | ||||
| SEEL | SEELOS THERAPEUTICS INC | $3.91M | $0.29 | N/A | N/A | N/A | N/A | 461.00% | N/A | N/A | N/A | ||||
| MOR | MORPHOSYS AG | $2.73B | $18.13 | $12.13 | -33.12% | Buy | 4 | 28.17% | N/A | N/A | N/A | ||||
| FENC | FENNEC PHARMACEUTICALS INC | $248.24M | $9.16 | $18.00 | 96.51% | Buy | 2 | 65.54% | N/A | N/A | N/A | ||||
| SGMO | SANGAMO THERAPEUTICS INC | $89.99M | $0.50 | $2.67 | 430.22% | Hold | 3 | -21.89% | N/A | N/A | N/A | ||||
| GERN | GERON CORP | $1.94B | $3.56 | $5.33 | 49.80% | Strong Buy | 3 | 1,123.05% | N/A | N/A | N/A | ||||
| FNCH | FINCH THERAPEUTICS GROUP INC | $3.60M | $2.24 | N/A | N/A | N/A | N/A | 1,080.98% | N/A | N/A | N/A | ||||
| TNXP | TONIX PHARMACEUTICALS HOLDING CORP | $13.52M | $0.16 | $3.00 | 1,775.00% | Strong Buy | 1 | 167.40% | N/A | N/A | N/A | ||||
| EYEN | EYENOVIA INC | $33.69M | $0.71 | $12.00 | 1,587.76% | Buy | 1 | 1,927.45% | N/A | N/A | N/A | ||||
| PYPD | POLYPID LTD | $7.95M | $4.81 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| BTAI | BIOXCEL THERAPEUTICS INC | $79.81M | $2.61 | $7.00 | 168.20% | Strong Buy | 4 | 199.96% | N/A | N/A | N/A | ||||
| PEPG | PEPGEN INC | $378.55M | $11.70 | $20.00 | 70.94% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| GLSI | GREENWICH LIFESCIENCES INC | $158.92M | $12.34 | $36.00 | 191.73% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| ENLV | ENLIVEX THERAPEUTICS LTD | $26.97M | $1.45 | $7.00 | 382.76% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| ONCY | ONCOLYTICS BIOTECH INC | $80.38M | $1.08 | $4.00 | 270.37% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| GTBP | GT BIOPHARMA INC | $5.18M | $3.75 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| KPTI | KARYOPHARM THERAPEUTICS INC | $121.97M | $1.06 | $5.33 | 403.11% | Strong Buy | 3 | 18.45% | N/A | N/A | N/A | ||||
| VIRI | VIRIOS THERAPEUTICS INC | $8.78M | $0.46 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| NERV | MINERVA NEUROSCIENCES INC | $16.99M | $2.43 | $11.00 | 352.67% | Hold | 1 | N/A | N/A | N/A | N/A | ||||
| SLDB | SOLID BIOSCIENCES INC | $322.44M | $8.54 | $20.33 | 138.09% | Strong Buy | 6 | N/A | N/A | N/A | N/A | ||||
| APGE | APOGEE THERAPEUTICS INC | $2.32B | $45.86 | $69.67 | 51.91% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| TNYA | TENAYA THERAPEUTICS INC | $331.34M | $4.22 | $15.75 | 273.22% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| VIRX | VIRACTA THERAPEUTICS INC | $33.26M | $0.85 | $7.67 | 805.19% | Buy | 3 | N/A | N/A | N/A | N/A | ||||
| MLYS | MINERALYS THERAPEUTICS INC | $547.93M | $11.04 | $30.00 | 171.74% | Strong Buy | 1 | N/A | N/A | N/A | N/A | ||||
| GNPX | GENPREX INC | $4.05M | $2.12 | $10.00 | 371.70% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| RPHM | RENEO PHARMACEUTICALS INC | $55.14M | $1.65 | $1.43 | -13.15% | Hold | 3 | N/A | N/A | N/A | N/A | ||||
| SCPX | SCORPIUS HOLDINGS INC | $4.25M | $0.16 | N/A | N/A | N/A | N/A | 246.35% | N/A | N/A | N/A | ||||
| FWBI | FIRST WAVE BIOPHARMA INC | $5.53M | $2.73 | $36.00 | 1,218.68% | Strong Buy | 1 | N/A | N/A | N/A | N/A | ||||
| VTYX | VENTYX BIOSCIENCES INC | $240.56M | $4.06 | $9.33 | 129.88% | Buy | 6 | N/A | N/A | N/A | N/A | ||||
| TLSA | TIZIANA LIFE SCIENCES LTD | $86.01M | $0.84 | N/A | N/A | N/A | N/A | N/A | N/A | -167.22% | -123.61% | ||||
| MGTX | MEIRAGTX HOLDINGS PLC | $302.46M | $4.71 | $11.00 | 133.55% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| ALLK | ALLAKOS INC | $88.75M | $1.01 | $1.83 | 81.49% | Hold | 3 | N/A | N/A | N/A | N/A | ||||
| ENVB | ENVERIC BIOSCIENCES INC | $6.56M | $0.90 | $10.00 | 1,011.11% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| THAR | THARIMMUNE INC | $4.24M | $0.36 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| AZTR | AZITRA INC | $6.34M | $0.22 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| CYCC | CYCLACEL PHARMACEUTICALS INC | $2.11M | $1.60 | $21.00 | 1,212.50% | Strong Buy | 1 | 549.49% | N/A | N/A | N/A | ||||
| RVNC | REVANCE THERAPEUTICS INC | $290.22M | $3.29 | $13.43 | 308.18% | Buy | 7 | 30.24% | N/A | N/A | N/A | ||||
| SLN | SILENCE THERAPEUTICS PLC | $855.63M | $21.62 | $57.25 | 164.80% | Strong Buy | 4 | 6.79% | N/A | N/A | N/A | ||||
| CAPR | CAPRICOR THERAPEUTICS INC | $161.71M | $5.15 | $24.00 | 366.02% | Strong Buy | 2 | 7.75% | N/A | N/A | N/A | ||||
| XFOR | X4 PHARMACEUTICALS INC | $189.77M | $1.13 | $2.00 | 76.99% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| CMMB | CHEMOMAB THERAPEUTICS LTD | $9.36M | $0.66 | $7.00 | 962.22% | Strong Buy | 1 | N/A | N/A | -8,022.91% | -6,156.18% | ||||
| XTLB | XTL BIOPHARMACEUTICALS LTD | $13.08M | $2.40 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| PHVS | PHARVARIS NV | $1.19B | $22.77 | $32.50 | 42.73% | Buy | 4 | N/A | N/A | N/A | N/A | ||||
| APLT | APPLIED THERAPEUTICS INC | $447.90M | $4.23 | $11.00 | 160.05% | Strong Buy | 4 | 102.19% | N/A | N/A | N/A | ||||
| MBRX | MOLECULIN BIOTECH INC | $9.60M | $4.31 | $35.00 | 712.44% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| SLRX | SALARIUS PHARMACEUTICALS INC | $2.15M | $0.50 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| LENZ | LENZ THERAPEUTICS INC | $128.54M | $15.45 | $31.33 | 102.80% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| BLTE | BELITE BIO INC | $1.11B | $38.00 | $58.67 | 54.39% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| BMEA | BIOMEA FUSION INC | $375.76M | $10.47 | $55.80 | 432.95% | Buy | 5 | N/A | N/A | N/A | N/A | ||||
| INSM | INSMED INC | $3.70B | $24.92 | $45.86 | 84.02% | Strong Buy | 7 | 34.49% | N/A | N/A | N/A | ||||
| RLYB | RALLYBIO CORP | $62.39M | $1.65 | $8.90 | 439.39% | Buy | 5 | N/A | N/A | N/A | N/A | ||||
| TARA | PROTARA THERAPEUTICS INC | $34.87M | $3.05 | $26.50 | 768.85% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| SYRE | SPYRE THERAPEUTICS INC | $1.17B | $32.47 | $38.00 | 17.03% | Strong Buy | 4 | 4.12% | N/A | N/A | N/A | ||||
| EDSA | EDESA BIOTECH INC | $14.17M | $4.47 | $21.00 | 370.01% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| HLVX | HILLEVAX INC | $597.40M | $12.02 | $30.67 | 155.13% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| RARE | ULTRAGENYX PHARMACEUTICAL INC | $3.61B | $43.85 | $80.80 | 84.26% | Strong Buy | 10 | 23.26% | N/A | N/A | N/A | ||||
| GHRS | GH RESEARCH PLC | $546.30M | $10.50 | $39.50 | 276.19% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| PDSB | PDS BIOTECHNOLOGY CORP | $119.57M | $3.26 | $17.33 | 431.69% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| IMMX | IMMIX BIOPHARMA INC | $55.43M | $2.10 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| CRIS | CURIS INC | $85.58M | $14.52 | $26.00 | 79.06% | Strong Buy | 2 | 0.28% | N/A | N/A | N/A | ||||
| CMND | CLEARMIND MEDICINE INC | $3.80M | $1.20 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| OPT | OPTHEA LTD | $211.97M | $3.63 | N/A | N/A | N/A | N/A | 461.95% | N/A | N/A | N/A | ||||
| GNTA | GENENTA SCIENCE SPA | $53.08M | $2.91 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| TPST | TEMPEST THERAPEUTICS INC | $77.23M | $3.48 | $25.00 | 618.39% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| AIM | AIM IMMUNOTECH INC | $20.26M | $0.41 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Biotech Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.